Global and Japan Pet Medication Market Insights, Forecast to 2026

Publisher Name :
Date: 25-Sep-2020
No. of pages: 145
Inquire Before Buying

Pet Medication market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Pet Medication market is segmented into

- Antibiotics

- Antifungal

- Flea Products

Segment by Application, the Pet Medication market is segmented into

- Cat

- Dog

- Horse

- Fish

- Other

Regional and Country-level Analysis

The Pet Medication market is analysed and market size information is provided by regions (countries).

The key regions covered in the Pet Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pet Medication Market Share Analysis

Pet Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Medication business, the date to enter into the Pet Medication market, Pet Medication product introduction, recent developments, etc.

The major vendors covered:

- Zoetis

- Merck

- Elanco

- Bayer

- Boehringer

- Novartis

- Virbac

- Ceva

- Vetoquinol

- Nexvet

- Aratana Therapeutics

- Kindred Biosciences

- Ambrx

- Entest Biomedical

- Taconic Biosciences

Global and Japan Pet Medication Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pet Medication Product Introduction
1.2 Market Segments
1.3 Key Pet Medication Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pet Medication Market Size Growth Rate by Type
1.4.2 Antibiotics
1.4.3 Antifungal
1.4.4 Flea Products
1.5 Market by Application
1.5.1 Global Pet Medication Market Size Growth Rate by Application
1.5.2 Cat
1.5.3 Dog
1.5.4 Horse
1.5.5 Fish
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pet Medication Market Size, Estimates and Forecasts
2.1.1 Global Pet Medication Revenue 2015-2026
2.1.2 Global Pet Medication Sales 2015-2026
2.2 Global Pet Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Pet Medication Historical Market Size by Region (2015-2020)
2.3.1 Global Pet Medication Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Pet Medication Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Pet Medication Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Pet Medication Sales Forecast by Region (2021-2026)
2.4.2 Global Pet Medication Revenue Forecast by Region (2021-2026)
3 Global Pet Medication Competitor Landscape by Players
3.1 Global Top Pet Medication Sales by Manufacturers
3.1.1 Global Pet Medication Sales by Manufacturers (2015-2020)
3.1.2 Global Pet Medication Sales Market Share by Manufacturers (2015-2020)
3.2 Global Pet Medication Manufacturers by Revenue
3.2.1 Global Pet Medication Revenue by Manufacturers (2015-2020)
3.2.2 Global Pet Medication Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pet Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pet Medication Revenue in 2019
3.2.5 Global Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pet Medication Price by Manufacturers
3.4 Global Pet Medication Manufacturing Base Distribution, Product Types
3.4.1 Pet Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pet Medication Product Type
3.4.3 Date of International Manufacturers Enter into Pet Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pet Medication Market Size by Type (2015-2020)
4.1.1 Global Pet Medication Sales by Type (2015-2020)
4.1.2 Global Pet Medication Revenue by Type (2015-2020)
4.1.3 Pet Medication Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pet Medication Market Size Forecast by Type (2021-2026)
4.2.1 Global Pet Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Pet Medication Revenue Forecast by Type (2021-2026)
4.2.3 Pet Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pet Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pet Medication Market Size by Application (2015-2020)
5.1.1 Global Pet Medication Sales by Application (2015-2020)
5.1.2 Global Pet Medication Revenue by Application (2015-2020)
5.1.3 Pet Medication Price by Application (2015-2020)
5.2 Pet Medication Market Size Forecast by Application (2021-2026)
5.2.1 Global Pet Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Pet Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Pet Medication Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Pet Medication Market Size YoY Growth 2015-2026
6.1.1 Japan Pet Medication Sales YoY Growth 2015-2026
6.1.2 Japan Pet Medication Revenue YoY Growth 2015-2026
6.1.3 Japan Pet Medication Market Share in Global Market 2015-2026
6.2 Japan Pet Medication Market Size by Players (International and Local Players)
6.2.1 Japan Top Pet Medication Players by Sales (2015-2020)
6.2.2 Japan Top Pet Medication Players by Revenue (2015-2020)
6.3 Japan Pet Medication Historic Market Review by Type (2015-2020)
6.3.1 Japan Pet Medication Sales Market Share by Type (2015-2020)
6.3.2 Japan Pet Medication Revenue Market Share by Type (2015-2020)
6.3.3 Japan Pet Medication Price by Type (2015-2020)
6.4 Japan Pet Medication Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Pet Medication Sales Forecast by Type (2021-2026)
6.4.2 Japan Pet Medication Revenue Forecast by Type (2021-2026)
6.4.3 Japan Pet Medication Price Forecast by Type (2021-2026)
6.5 Japan Pet Medication Historic Market Review by Application (2015-2020)
6.5.1 Japan Pet Medication Sales Market Share by Application (2015-2020)
6.5.2 Japan Pet Medication Revenue Market Share by Application (2015-2020)
6.5.3 Japan Pet Medication Price by Application (2015-2020)
6.6 Japan Pet Medication Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Pet Medication Sales Forecast by Application (2021-2026)
6.6.2 Japan Pet Medication Revenue Forecast by Application (2021-2026)
6.6.3 Japan Pet Medication Price Forecast by Application (2021-2026)
7 North America
7.1 North America Pet Medication Market Size YoY Growth 2015-2026
7.2 North America Pet Medication Market Facts & Figures by Country
7.2.1 North America Pet Medication Sales by Country (2015-2020)
7.2.2 North America Pet Medication Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Pet Medication Market Size YoY Growth 2015-2026
8.2 Europe Pet Medication Market Facts & Figures by Country
8.2.1 Europe Pet Medication Sales by Country
8.2.2 Europe Pet Medication Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pet Medication Market Size YoY Growth 2015-2026
9.2 Asia Pacific Pet Medication Market Facts & Figures by Country
9.2.1 Asia Pacific Pet Medication Sales by Region (2015-2020)
9.2.2 Asia Pacific Pet Medication Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Pet Medication Market Size YoY Growth 2015-2026
10.2 Latin America Pet Medication Market Facts & Figures by Country
10.2.1 Latin America Pet Medication Sales by Country
10.2.2 Latin America Pet Medication Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pet Medication Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Pet Medication Market Facts & Figures by Country
11.2.1 Middle East and Africa Pet Medication Sales by Country
11.2.2 Middle East and Africa Pet Medication Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Zoetis
12.1.1 Zoetis Corporation Information
12.1.2 Zoetis Description and Business Overview
12.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Zoetis Pet Medication Products Offered
12.1.5 Zoetis Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Pet Medication Products Offered
12.2.5 Merck Recent Development
12.3 Elanco
12.3.1 Elanco Corporation Information
12.3.2 Elanco Description and Business Overview
12.3.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Elanco Pet Medication Products Offered
12.3.5 Elanco Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Description and Business Overview
12.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer Pet Medication Products Offered
12.4.5 Bayer Recent Development
12.5 Boehringer
12.5.1 Boehringer Corporation Information
12.5.2 Boehringer Description and Business Overview
12.5.3 Boehringer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Boehringer Pet Medication Products Offered
12.5.5 Boehringer Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Pet Medication Products Offered
12.6.5 Novartis Recent Development
12.7 Virbac
12.7.1 Virbac Corporation Information
12.7.2 Virbac Description and Business Overview
12.7.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Virbac Pet Medication Products Offered
12.7.5 Virbac Recent Development
12.8 Ceva
12.8.1 Ceva Corporation Information
12.8.2 Ceva Description and Business Overview
12.8.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ceva Pet Medication Products Offered
12.8.5 Ceva Recent Development
12.9 Vetoquinol
12.9.1 Vetoquinol Corporation Information
12.9.2 Vetoquinol Description and Business Overview
12.9.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Vetoquinol Pet Medication Products Offered
12.9.5 Vetoquinol Recent Development
12.10 Nexvet
12.10.1 Nexvet Corporation Information
12.10.2 Nexvet Description and Business Overview
12.10.3 Nexvet Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nexvet Pet Medication Products Offered
12.10.5 Nexvet Recent Development
12.11 Zoetis
12.11.1 Zoetis Corporation Information
12.11.2 Zoetis Description and Business Overview
12.11.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zoetis Pet Medication Products Offered
12.11.5 Zoetis Recent Development
12.12 Kindred Biosciences
12.12.1 Kindred Biosciences Corporation Information
12.12.2 Kindred Biosciences Description and Business Overview
12.12.3 Kindred Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Kindred Biosciences Products Offered
12.12.5 Kindred Biosciences Recent Development
12.13 Ambrx
12.13.1 Ambrx Corporation Information
12.13.2 Ambrx Description and Business Overview
12.13.3 Ambrx Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Ambrx Products Offered
12.13.5 Ambrx Recent Development
12.14 Entest Biomedical
12.14.1 Entest Biomedical Corporation Information
12.14.2 Entest Biomedical Description and Business Overview
12.14.3 Entest Biomedical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Entest Biomedical Products Offered
12.14.5 Entest Biomedical Recent Development
12.15 Taconic Biosciences
12.15.1 Taconic Biosciences Corporation Information
12.15.2 Taconic Biosciences Description and Business Overview
12.15.3 Taconic Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Taconic Biosciences Products Offered
12.15.5 Taconic Biosciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pet Medication Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pet Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Pet Medication Market Segments
Table 2. Ranking of Global Top Pet Medication Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pet Medication Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antibiotics
Table 5. Major Manufacturers of Antifungal
Table 6. Major Manufacturers of Flea Products
Table 7. Global Pet Medication Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Pet Medication Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Pet Medication Sales by Regions 2015-2020 (K MT)
Table 10. Global Pet Medication Sales Market Share by Regions (2015-2020)
Table 11. Global Pet Medication Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pet Medication Sales Forecast by Region (2021-2026) (K MT)
Table 13. Global Pet Medication Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Pet Medication Sales Share by Manufacturers (2015-2020)
Table 15. Global Pet Medication Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Pet Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Medication as of 2019)
Table 17. Pet Medication Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Pet Medication Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Pet Medication Price (2015-2020) (USD/MT)
Table 20. Pet Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Pet Medication Product Type
Table 22. Date of International Manufacturers Enter into Pet Medication Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Pet Medication Sales by Type (2015-2020) (K MT)
Table 25. Global Pet Medication Sales Share by Type (2015-2020)
Table 26. Global Pet Medication Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Pet Medication Revenue Share by Type (2015-2020)
Table 28. Pet Medication Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Pet Medication Sales Share by Type (2021-2026)
Table 30. Global Pet Medication Sales by Application (2015-2020) (K MT)
Table 31. Global Pet Medication Sales Share by Application (2015-2020)
Table 32. Global Pet Medication Sales Share by Application (2021-2026)
Table 33. Global Pet Medication Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Pet Medication Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Pet Medication Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan Pet Medication Sales (K MT) of Key Companies (2015-2020)
Table 37. Japan Pet Medication Sales Share by Company (2015-2020)
Table 38. Japan Pet Medication Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan Pet Medication Sales (K MT) by Type (2015-2020)
Table 40. Japan Pet Medication Sales Share by Type (2015-2020)
Table 41. Japan Pet Medication Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan Pet Medication Price (K MT) by Type (2015-2020)
Table 43. Japan Pet Medication Sales (K MT) by Type (2021-2026)
Table 44. Japan Pet Medication Sales Share by Type (2021-2026)
Table 45. Japan Pet Medication Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan Pet Medication Revenue Share by Type (2021-2026)
Table 47. Japan Pet Medication Price (K MT) by Type (2021-2026)
Table 48. Japan Pet Medication Sales (K MT) by Application (2015-2020)
Table 49. Japan Pet Medication Sales Share by Application (2015-2020)
Table 50. Japan Pet Medication Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan Pet Medication Sales (K MT) by Application (2021-2026)
Table 52. Japan Pet Medication Sales Share by Application (2021-2026)
Table 53. Japan Pet Medication Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan Pet Medication Revenue Share by Application (2021-2026)
Table 55. North America Pet Medication Sales by Country (2015-2020) (K MT)
Table 56. North America Pet Medication Sales Market Share by Country (2015-2020)
Table 57. North America Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Pet Medication Revenue Market Share by Country (2015-2020)
Table 59. Europe Pet Medication Sales by Country (2015-2020) (K MT)
Table 60. Europe Pet Medication Sales Market Share by Country (2015-2020)
Table 61. Europe Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Pet Medication Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Pet Medication Sales by Region (2015-2020) (K MT)
Table 64. Asia Pacific Pet Medication Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Pet Medication Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Pet Medication Revenue Market Share by Region (2015-2020)
Table 67. Latin America Pet Medication Sales by Country (2015-2020) (K MT)
Table 68. Latin America Pet Medication Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Pet Medication Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Pet Medication Sales by Country (2015-2020) (K MT)
Table 72. Middle East and Africa Pet Medication Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Pet Medication Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Pet Medication Revenue Market Share by Country (2015-2020)
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Zoetis Pet Medication Product
Table 79. Zoetis Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Elanco Product
Table 89. Elanco Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Bayer Product
Table 94. Bayer Recent Development
Table 95. Boehringer Corporation Information
Table 96. Boehringer Description and Business Overview
Table 97. Boehringer Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Boehringer Product
Table 99. Boehringer Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis Product
Table 104. Novartis Recent Development
Table 105. Virbac Corporation Information
Table 106. Virbac Description and Business Overview
Table 107. Virbac Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Virbac Product
Table 109. Virbac Recent Development
Table 110. Ceva Corporation Information
Table 111. Ceva Description and Business Overview
Table 112. Ceva Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Ceva Product
Table 114. Ceva Recent Development
Table 115. Vetoquinol Corporation Information
Table 116. Vetoquinol Description and Business Overview
Table 117. Vetoquinol Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Vetoquinol Product
Table 119. Vetoquinol Recent Development
Table 120. Nexvet Corporation Information
Table 121. Nexvet Description and Business Overview
Table 122. Nexvet Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Nexvet Product
Table 124. Nexvet Recent Development
Table 125. Aratana Therapeutics Corporation Information
Table 126. Aratana Therapeutics Description and Business Overview
Table 127. Aratana Therapeutics Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Aratana Therapeutics Product
Table 129. Aratana Therapeutics Recent Development
Table 130. Kindred Biosciences Corporation Information
Table 131. Kindred Biosciences Description and Business Overview
Table 132. Kindred Biosciences Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Kindred Biosciences Product
Table 134. Kindred Biosciences Recent Development
Table 135. Ambrx Corporation Information
Table 136. Ambrx Description and Business Overview
Table 137. Ambrx Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Ambrx Product
Table 139. Ambrx Recent Development
Table 140. Entest Biomedical Corporation Information
Table 141. Entest Biomedical Description and Business Overview
Table 142. Entest Biomedical Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Entest Biomedical Product
Table 144. Entest Biomedical Recent Development
Table 145. Taconic Biosciences Corporation Information
Table 146. Taconic Biosciences Description and Business Overview
Table 147. Taconic Biosciences Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Taconic Biosciences Product
Table 149. Taconic Biosciences Recent Development
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Main Points Interviewed from Key Pet Medication Players
Table 154. Pet Medication Customers List
Table 155. Pet Medication Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Medication Product Picture
Figure 2. Global Pet Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Antibiotics Product Picture
Figure 4. Antifungal Product Picture
Figure 5. Flea Products Product Picture
Figure 6. Global Pet Medication Sales Market Share by Application in 2020 & 2026
Figure 7. Cat
Figure 8. Dog
Figure 9. Horse
Figure 10. Fish
Figure 11. Other
Figure 12. Pet Medication Report Years Considered
Figure 13. Global Pet Medication Market Size 2015-2026 (US$ Million)
Figure 14. Global Pet Medication Sales 2015-2026 (K MT)
Figure 15. Global Pet Medication Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Pet Medication Sales Market Share by Region (2015-2020)
Figure 17. Global Pet Medication Sales Market Share by Region in 2019
Figure 18. Global Pet Medication Revenue Market Share by Region (2015-2020)
Figure 19. Global Pet Medication Revenue Market Share by Region in 2019
Figure 20. Global Pet Medication Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Pet Medication Revenue in 2019
Figure 22. Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Pet Medication Sales Market Share by Type (2015-2020)
Figure 24. Global Pet Medication Sales Market Share by Type in 2019
Figure 25. Global Pet Medication Revenue Market Share by Type (2015-2020)
Figure 26. Global Pet Medication Revenue Market Share by Type in 2019
Figure 27. Global Pet Medication Market Share by Price Range (2015-2020)
Figure 28. Global Pet Medication Sales Market Share by Application (2015-2020)
Figure 29. Global Pet Medication Sales Market Share by Application in 2019
Figure 30. Global Pet Medication Revenue Market Share by Application (2015-2020)
Figure 31. Global Pet Medication Revenue Market Share by Application in 2019
Figure 32. Japan Pet Medication Sales Growth Rate 2015-2026 (K MT)
Figure 33. Japan Pet Medication Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. Japan Pet Medication Market Share in Global Market 2015-2026
Figure 35. Japan 5 and 10 Largest Pet Medication Players Market Share by Revenue in Pet Medication in 2019
Figure 36. Japan Pet Medication Revenue Share by Type (2015-2020)
Figure 37. Japan Pet Medication Revenue Growth Rate by Type in 2015 & 2019
Figure 38. Japan Pet Medication Revenue Share by Application (2015-2020)
Figure 39. Japan Pet Medication Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 41. North America Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Pet Medication Sales Market Share by Country in 2019
Figure 43. North America Pet Medication Revenue Market Share by Country in 2019
Figure 44. U.S. Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 45. U.S. Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 47. Canada Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 49. Europe Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Pet Medication Sales Market Share by Country in 2019
Figure 51. Europe Pet Medication Revenue Market Share by Country in 2019
Figure 52. Germany Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 53. Germany Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 55. France Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 57. U.K. Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 59. Italy Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 61. Russia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Pet Medication Sales Market Share by Region in 2019
Figure 65. Asia Pacific Pet Medication Revenue Market Share by Region in 2019
Figure 66. China Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 89. Latin America Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Pet Medication Sales Market Share by Country in 2019
Figure 91. Latin America Pet Medication Revenue Market Share by Country in 2019
Figure 92. Mexico Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 93. Mexico Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 95. Brazil Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 97. Argentina Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Middle East and Africa Pet Medication Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Pet Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Pet Medication Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Pet Medication Revenue Market Share by Country in 2019
Figure 102. Turkey Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Pet Medication Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Pet Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Porter's Five Forces Analysis
Figure 109. Pet Medication Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs